|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,522.00 JPY | -0.37% |
|
+0.97% | -8.75% |
| 06-15 | Goldman Sachs Upgrades Chugai Pharmaceutical to Buy from Neutral; Price Target is 8,950 Yen | MT |
| 05-26 | Major Asian Stock Markets Fall Amid Renewed Middle East Tensions | MT |
| Market Cap | 12,379B 76.7B 67.02B 61.99B 57.86B 109B 7,248B 109B 737B 287B 3,563B 288B 282B | P/E 2026 * |
24.2x | P/E 2027 * | 20.9x |
|---|---|---|---|---|---|
| Enterprise Value | 11,457B 70.98B 62.02B 57.37B 53.55B 101B 6,708B 101B 682B 265B 3,298B 266B 261B | EV / Sales 2026 * |
8.26x | EV / Sales 2027 * | 7.3x |
| Free-Float |
38.12% | Yield 2026 * |
1.82% | Yield 2027 * | 2.08% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | -0.37% | ||
| 1 week | +0.97% | ||
| Current month | -4.69% | ||
| 1 month | -4.01% | ||
| 3 months | -13.04% | ||
| 6 months | -9.28% | ||
| Current year | -8.75% |
| 1 week | 7,386 | 7,719 | |
| 1 month | 7,270 | 8,215 | |
| Current year | 7,270 | 10,700 | |
| 1 year | 5,942 | 10,700 | |
| 3 years | 3,767 | 10,700 | |
| 5 years | 3,191 | 10,700 | |
| 10 years | 1,003.33 | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 2020-12-31 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | - | 2024-03-27 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Motoo Ueno
BRD | Director/Board Member | 68 | 1993-02-28 |
Masayuki Oku
BRD | Director/Board Member | 81 | 2015-02-28 |
| Director/Board Member | 77 | 2017-02-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.37% | +0.97% | +4.63% | +74.77% | 77.05B | ||
| +1.19% | -1.63% | +44.16% | +142.74% | 980B | ||
| +1.16% | -1.83% | +52.88% | +39.68% | 550B | ||
| +6.94% | +4.52% | +26.04% | +68.56% | 382B | ||
| -0.06% | -3.09% | +23.33% | +16.78% | 316B | ||
| +0.42% | +0.68% | +27.54% | +14.57% | 272B | ||
| +1.67% | +0.05% | +26.50% | +33.56% | 268B | ||
| +2.39% | +5.02% | -33.44% | -44.76% | 199B | ||
| +1.94% | -1.62% | +26.57% | +50.15% | 182B | ||
| +0.58% | +0.31% | +17.41% | +59.62% | 154B | ||
| Average | +1.57% | -2.29% | +21.56% | +45.57% | 337.94B | |
| Weighted average by Cap. | +1.71% | -3.39% | +31.21% | +65.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,387B 8.59B 7.51B 6.95B 6.48B 12.17B 812B 12.26B 82.53B 32.11B 399B 32.26B 31.56B | 1,535B 9.51B 8.31B 7.69B 7.17B 13.47B 899B 13.57B 91.35B 35.54B 442B 35.71B 34.93B |
| Net income | 511B 3.16B 2.76B 2.56B 2.39B 4.48B 299B 4.51B 30.39B 11.82B 147B 11.88B 11.62B | 593B 3.67B 3.21B 2.97B 2.77B 5.2B 347B 5.24B 35.3B 13.73B 171B 13.8B 13.5B |
| Net Debt | -923B -5.72B -4.99B -4.62B -4.31B -8.09B -540B -8.15B -54.9B -21.36B -266B -21.46B -20.99B | -1,166B -7.22B -6.31B -5.84B -5.45B -10.23B -682B -10.3B -69.37B -26.99B -336B -27.12B -26.53B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-22 | 7,522.00 ¥ | -0.37% | 1,238,100 |
| 26-06-19 | 7,550.00 ¥ | -0.21% | 3,697,700 |
| 26-06-18 | 7,566.00 ¥ | -1.10% | 1,954,000 |
| 26-06-17 | 7,650.00 ¥ | +1.69% | 1,745,000 |
| 26-06-16 | 7,523.00 ¥ | +1.28% | 2,083,200 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions


















